None listed
Conditions
Brief summary
Participants will be randomised to 4 weeks of CPAP with Conventional Humidification (CH) or 4 weeks of CPAP with ThermoSmart Humidification. Once completed participants will be swapped to the alternate treatment arm. Sleep Quality via Actigraphy - designed to measure rest/activity cycles continuously throughout the 24-hr day. The instrument provides reliable and valid data regarding a number of sleep-related parameters, including Total Sleep Time (TST), (awake time spent awake after sleep onset (WASO) and Sleep Efficicney (SE) A 7 day period of actigraphy will be completed in the 7 days leading up to the participants first treatment. For the first week (7 days) of each arm actigraph data will be collected. Both trial administrator and subjects will be blinded. the devices are identical looking and neither administrator nor subject will know which is which.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
A previous diagnosis of OSA permitted, but patient must be novel to CPAP and no previous surgical intervention for OSA or treatment with an oral appliance.AHI = 15 OR AHI = 5 + ESS = 10 OR ESS = 10 + a medical co-morbidityPatient willing to give informed consent and follow study protocol.
Exclusion criteria
Wake resting SpO2 < 90%Patient requires BiLevel PAP or supplemental oxygenThe patient is medically unstable (e.g. respiratory or cardiac failure)Patient unwilling to give informed consent or follow study protocol.AHI: Apnea Hypopnea Index (degree of severity of OSA)ESS: Epworth Sleepiness Scale (degree of daytime sleepiness).